A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Recurrent/Metastatic Head and Neck Cancers

Clinical trial NCT04902027 · COMPLETED

Trial details

NCT number: NCT04902027
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Head and Neck Cancer Metastatic Head and Neck Cancer

Start date: 2021-07-01
Primary completion: 2023-10-23
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.